← Back
$DGX All transactions

QUEST DIAGNOSTICS INC

▼ SELL 10b5-1 Plan

$ Value

$73K

Shares

351

Price

$209

Filed

Feb 17

Insider

Name

Doherty Catherine T.

Title

EVP, Regional Businesses

CIK

0001520897

Roles

Officer

Transaction Details

Transaction Date

2026-02-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

68,068

Footnotes

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. | This transaction was executed in multiple trades at prices ranging from $204.745 to $205.740. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $205.770 to $206.7489. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $206.770 to $207.675. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $207.810 to $208.600. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $208.970 to $209.355. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. | The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.

Filing Info

Accession No.

0001022079-26-000009

Form Type

4

Issuer CIK

0001022079

Doherty Catherine T.'s History

Date Ticker Type Value
2026-02-19 DGX $294K
2026-02-18 DGX A $0
2026-02-18 DGX F $91K
2026-02-18 DGX F $151K
2026-02-18 DGX A $0
2026-02-13 DGX M $2.9M
2026-02-13 DGX $2.2M
2026-02-13 DGX $2.1M
2026-02-13 DGX $725K
2026-02-13 DGX $337K

Other Insiders at DGX (90d)

Insider Bought Sold Last
CARTER ROBERT B 2026-01-28
PREVOZNIK MICHAEL E
SVP & General Counsel
$228K 2026-02-19
WENTWORTH TIMOTHY C 2026-04-01
Plewman Patrick
SVP for Diagnostic Services
$1.4M 2026-02-19
Gregg Vicky B 2026-01-28
Doherty Catherine T.
EVP, Regional Businesses
$5.6M 2026-02-19
Davis J. E.
CEO and President
2026-02-18
SAMAD SAM
Executive Vice President & CFO
2026-02-18
Deppe Michael J
SVP, Corp. Controller & CAO
2026-02-18
Lassiter Wright III 2026-01-28
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
2026-02-18
DELANEY MARK E
SVP & Chief Commercial Officer
2026-02-18